An observational study in Celiac Disease in Children, sponsored by ASST Fatebenefratelli Sacco. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-19.
Sponsored by ASST Fatebenefratelli Sacco · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 61 studies in Celiac Disease with a site in Italy — 14 open to participants now, 16 under way, none of them phase 3. Celiac Disease · Italy.
Among the 61 studies in Celiac Disease with a site in Italy, this one is the 2nd largest by planned enrollment of the 26 observational ones that give a count, is one of 3 that started in 2024, is one of 26 observational ones, reaches primary completion later than 1 of the 15 other live ones, and was the 52nd registered.
353 studies on the registry are indexed under Celiac Disease; 78 are open to participants now.
Browse Celiac Disease studies →14 of the 61 studies in Celiac Disease with a site in Italy are open now. Recruiting first, the newest first:
University of Palermo · Sites in Italy
Ages 1–14
University of Palermo · Sites in Italy
Ages 18+
University of Bari · Sites in Italy
Ages 1–18
University of Pavia · Sites in Italy
Ages 18+
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 48 Celiac Disease studies recruiting now, 24 (50%) set no upper age limit and 19 (40%) stop at 75 or younger; 16 take children under 18; 13 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
61 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 900 is above the median of 185 across 134 observational studies indexed under Celiac Disease.
Median enrollment 50 across the 35 interventional studies, 207 across the 26 observational. Of the 30 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 61 have an industry lead sponsor. The 10 most frequent:
ASST Fatebenefratelli Sacco is the lead sponsor of 38 studies on the registry; 12 are open to participants now.
ASST Fatebenefratelli Sacco has 1 study filed under Celiac Disease — fewer than ten, so there is no comparison to draw.
4 of the studies in Celiac Disease with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07862101University of BariStrategy For Assessing The Risk Of Type 1 Diabetes In Pediatric Celiac Patients | 2026-12-30 |
| NCT07915063Istituti Clinici Scientifici Maugeri SpAImpact of Mediterranean Diet and Processed Food Consumption on Gastrointestinal Symptoms in Coeliac Patients on a Gluten-Free Diet | 2026-12-31 |
| NCT03017716University of PalermoInflammatory Back Pain and Gluten Free Diet | 2027-01-01 |
| NCT07584473University of PalermoNCWS or IBS/FD in Relatives of CD Patients | 2027-04-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 61 studies in Celiac Disease with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A retrospective monocentric observational no-profit study with the aim of evaluating the entity and potential variables influencing the catch-up growth of childhood gluten-free diet patients with celiac disease during a 10-year follow-up. The only extrapolation of the data collected in anonymized form from the medical records of patients who match the necessary study criteria will be planned in order to achieve this aim. A 900-patient sample size will be planned.
Childhood celiac disease patients on a gluten-free diet
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Measure the catch-up growth degree.
Changes in the auxological weight variable in pediatric patients with celiac disease were measured 6 months and 24 months after they started a gluten-free diet. The change was expressed as an average daily weight increase and compared with the average increase expected for sex and age in a healthy population extrapolated from validated curves (Cacciari).
Time frame: 6 and 24 month
Calculate the degree of catch-up growth
Variation in the auxological variable of height in pediatric patients with celiac disease, measured as variation in the standard deviation of this variable compared to reference values for age and sex extrapolated from validated curves (Cacciari curves), at six and twenty-four months after the start of the gluten-free diet.
Time frame: 6 and 24 month
Exploratory objectives 1
Identify the correlation between the degree of catch-up growth and the persistence of the symptoms, MC-related antibody positivity and the level of diet adherence at the 6- and 24-month follow-up
Time frame: 6 and 24 month
Exploratory objectives 2
Define the degree of celiac disease's clinical, endoscopic, histological, and serological severity at the time the sample was diagnosed, and then correlate it to the degree of catch-up growth that occurred 6 and 24 months after the gluten-free diet was started
Time frame: 6 and 24 month
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2024 (actual). Primary completion is estimated for Dec 2024, 5 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ASST Fatebenefratelli Sacco